Search research articles
Contact Us
Filters
Showing results (141-150 of 248) with videos related to
Page
of 25
Sort By:
Zoonoses and Public Health
|
June 7, 2014
Conducting systematic reviews of intervention questions I: Writing the review protocol, formulating the question and searching the literature
A M O'Connor, K M Anderson, C K Goodell, et al.
Medical Hypotheses
|
June 11, 1999
Does maximizing programmed cell death necessarily yield an optimum clinical advantage?
D Ou, K M Anderson, W Leslie, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats
K M Anderson, A D Eckhart, R N Willette, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
June 1, 1990
Tumor cell mitochondrial matrix/cristae complexes as potential sites for anticancer therapy with polyunsaturated fatty acid analogues
K M Anderson, T Seed, F Ondrey, et al.
JAMA
|
July 7, 1989
Impact of national guidelines for cholesterol risk factor screening. The Framingham Offspring Study
P W Wilson, J C Christiansen, K M Anderson, et al.
Circulation
|
January 1, 1991
An updated coronary risk profile. A statement for health professionals
K M Anderson, P W Wilson, P M Odell, et al.
American Heart Journal
|
January 1, 1991
Cardiovascular disease risk profiles
K M Anderson, P M Odell, P W Wilson, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 1, 1993
Decline in defibrillation thresholds
M W Kroll, K M Anderson, C G Supino, et al.
Anticancer Research
|
December 22, 1998
NTBN, a free radical spin trap induces programmed cell death in human pancreatic cancer (PANC-1) cells
K M Anderson, T Seed, W Alrefai, et al.
The American Journal of Cardiology
|
July 1, 1988
Antihypertensive drug therapy and arrhythmia risk
D Levy, K M Anderson, J C Christiansen, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 248) with videos related to
Sort By:
Page
of 25
Zoonoses and Public Health
|
June 7, 2014
Conducting systematic reviews of intervention questions I: Writing the review protocol, formulating the question and searching the literature
A M O'Connor, K M Anderson, C K Goodell, et al.
Medical Hypotheses
|
June 11, 1999
Does maximizing programmed cell death necessarily yield an optimum clinical advantage?
D Ou, K M Anderson, W Leslie, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats
K M Anderson, A D Eckhart, R N Willette, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
June 1, 1990
Tumor cell mitochondrial matrix/cristae complexes as potential sites for anticancer therapy with polyunsaturated fatty acid analogues
K M Anderson, T Seed, F Ondrey, et al.
JAMA
|
July 7, 1989
Impact of national guidelines for cholesterol risk factor screening. The Framingham Offspring Study
P W Wilson, J C Christiansen, K M Anderson, et al.
Circulation
|
January 1, 1991
An updated coronary risk profile. A statement for health professionals
K M Anderson, P W Wilson, P M Odell, et al.
American Heart Journal
|
January 1, 1991
Cardiovascular disease risk profiles
K M Anderson, P M Odell, P W Wilson, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 1, 1993
Decline in defibrillation thresholds
M W Kroll, K M Anderson, C G Supino, et al.
Anticancer Research
|
December 22, 1998
NTBN, a free radical spin trap induces programmed cell death in human pancreatic cancer (PANC-1) cells
K M Anderson, T Seed, W Alrefai, et al.
The American Journal of Cardiology
|
July 1, 1988
Antihypertensive drug therapy and arrhythmia risk
D Levy, K M Anderson, J C Christiansen, et al.
Page
of 25